The role of next‐generation sequencing in the investigation of ultrasound‐identified fetal structural anomalies

Mark Kilby

doi:10.1111/1471-0528.16533

The role of next‐generation sequencing in the investigation of ultrasound‐identified fetal structural anomalies

Mark Kilby

Metabolism and Systems Research

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

192 Downloads (Pure)

Abstract

Fetal structural anomalies have an impact on fetal mortality and morbidity. Next-generation sequencing (NGS) may be incorporated into clinical pathways for investigation of paediatric morbidity but can also be used to delineate the prognosis of fetal anomalies. This paper reviews the role of NGS in the investigation of fetal malformations, the literature defining the clinical utility, the technique most commonly used and potential promise and challenges for implementation into clinical practice. Prospective case selection with informative pre-test counselling by multidisciplinary teams is imperative. Regulated laboratory sequencing, bioinformatic pathways with potential variant identification and conservative matching with the phenotype is important. Tweetable abstract: Prenatal exome sequencing in fetal structural anomalies yields diagnostic information in up to 20% of cases.

Original language	English
Pages (from-to)	420-429
Number of pages	10
Journal	BJOG: An International Journal of Obstetrics & Gynaecology
Volume	128
Issue number	2
Early online date	25 Sept 2020
DOIs	https://doi.org/10.1111/1471-0528.16533
Publication status	Published - Jan 2021

Bibliographical note

Funding Information:
MDK was an investigator and grant holder as part of the PAGE study. This represents research commissioned by the Health Innovation Challenge Fund (HICF‐R7‐396), a parallel funding partnership between the Department of Health and the Wellcome Trust. The views expressed in this publication are those of the author and not necessarily those of the Department of Health or the Wellcome Trust. MDK is also a member of the RCOG Genomics Taskforce, the RCOG representative of the Joint Committee on Genomics in Medicine (joint committee of the Royal College of Physicians, Royal College of Pathologists, Royal College of Paediatricians & Child Health, Royal of Obstetricians and Gynaecologists) and a member of the Fetal Group of the British Society of Genetic Medicine. A completed disclosure of interest form is available to view online as supporting information .

Funding Information:
I am grateful for the comments of Dr Denise Williams (Consultant Clinical Geneticist) and Dr Stephanie Allen (Senior Scientist and Prenatal lead for the West Midlands Genetics Research Laboratory) at Birmingham Women's and Children's Foundation Trust.

Publisher Copyright:
© 2020 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd

Keywords

Exome
fetus
genome
sequencing
structural abnormality

ASJC Scopus subject areas

Obstetrics and Gynaecology

Access to Document

10.1111/1471-0528.16533Licence: Creative Commons: Attribution (CC BY)

Kilby_2020_The_role_of_next‐generation_sequencing_BJOGFinal published version, 1.21 MBLicence: Creative Commons: Attribution (CC BY)

Cite this

@article{3798460b9028487a8bed6a69a2ddf30f,

title = "The role of next‐generation sequencing in the investigation of ultrasound‐identified fetal structural anomalies",

abstract = "Fetal structural anomalies have an impact on fetal mortality and morbidity. Next-generation sequencing (NGS) may be incorporated into clinical pathways for investigation of paediatric morbidity but can also be used to delineate the prognosis of fetal anomalies. This paper reviews the role of NGS in the investigation of fetal malformations, the literature defining the clinical utility, the technique most commonly used and potential promise and challenges for implementation into clinical practice. Prospective case selection with informative pre-test counselling by multidisciplinary teams is imperative. Regulated laboratory sequencing, bioinformatic pathways with potential variant identification and conservative matching with the phenotype is important. Tweetable abstract: Prenatal exome sequencing in fetal structural anomalies yields diagnostic information in up to 20% of cases.",

keywords = "Exome, fetus, genome, sequencing, structural abnormality",

author = "Mark Kilby",

note = "Funding Information: MDK was an investigator and grant holder as part of the PAGE study. This represents research commissioned by the Health Innovation Challenge Fund (HICF‐R7‐396), a parallel funding partnership between the Department of Health and the Wellcome Trust. The views expressed in this publication are those of the author and not necessarily those of the Department of Health or the Wellcome Trust. MDK is also a member of the RCOG Genomics Taskforce, the RCOG representative of the Joint Committee on Genomics in Medicine (joint committee of the Royal College of Physicians, Royal College of Pathologists, Royal College of Paediatricians & Child Health, Royal of Obstetricians and Gynaecologists) and a member of the Fetal Group of the British Society of Genetic Medicine. A completed disclosure of interest form is available to view online as supporting information . Funding Information: I am grateful for the comments of Dr Denise Williams (Consultant Clinical Geneticist) and Dr Stephanie Allen (Senior Scientist and Prenatal lead for the West Midlands Genetics Research Laboratory) at Birmingham Women's and Children's Foundation Trust. Publisher Copyright: {\textcopyright} 2020 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd",

year = "2021",

month = jan,

doi = "10.1111/1471-0528.16533",

language = "English",

volume = "128",

pages = "420--429",

journal = "BJOG: An International Journal of Obstetrics & Gynaecology",

issn = "1470-0328",

publisher = "Wiley",

number = "2",

}

TY - JOUR

T1 - The role of next‐generation sequencing in the investigation of ultrasound‐identified fetal structural anomalies

AU - Kilby, Mark

N1 - Funding Information: MDK was an investigator and grant holder as part of the PAGE study. This represents research commissioned by the Health Innovation Challenge Fund (HICF‐R7‐396), a parallel funding partnership between the Department of Health and the Wellcome Trust. The views expressed in this publication are those of the author and not necessarily those of the Department of Health or the Wellcome Trust. MDK is also a member of the RCOG Genomics Taskforce, the RCOG representative of the Joint Committee on Genomics in Medicine (joint committee of the Royal College of Physicians, Royal College of Pathologists, Royal College of Paediatricians & Child Health, Royal of Obstetricians and Gynaecologists) and a member of the Fetal Group of the British Society of Genetic Medicine. A completed disclosure of interest form is available to view online as supporting information . Funding Information: I am grateful for the comments of Dr Denise Williams (Consultant Clinical Geneticist) and Dr Stephanie Allen (Senior Scientist and Prenatal lead for the West Midlands Genetics Research Laboratory) at Birmingham Women's and Children's Foundation Trust. Publisher Copyright: © 2020 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd

PY - 2021/1

Y1 - 2021/1

N2 - Fetal structural anomalies have an impact on fetal mortality and morbidity. Next-generation sequencing (NGS) may be incorporated into clinical pathways for investigation of paediatric morbidity but can also be used to delineate the prognosis of fetal anomalies. This paper reviews the role of NGS in the investigation of fetal malformations, the literature defining the clinical utility, the technique most commonly used and potential promise and challenges for implementation into clinical practice. Prospective case selection with informative pre-test counselling by multidisciplinary teams is imperative. Regulated laboratory sequencing, bioinformatic pathways with potential variant identification and conservative matching with the phenotype is important. Tweetable abstract: Prenatal exome sequencing in fetal structural anomalies yields diagnostic information in up to 20% of cases.

AB - Fetal structural anomalies have an impact on fetal mortality and morbidity. Next-generation sequencing (NGS) may be incorporated into clinical pathways for investigation of paediatric morbidity but can also be used to delineate the prognosis of fetal anomalies. This paper reviews the role of NGS in the investigation of fetal malformations, the literature defining the clinical utility, the technique most commonly used and potential promise and challenges for implementation into clinical practice. Prospective case selection with informative pre-test counselling by multidisciplinary teams is imperative. Regulated laboratory sequencing, bioinformatic pathways with potential variant identification and conservative matching with the phenotype is important. Tweetable abstract: Prenatal exome sequencing in fetal structural anomalies yields diagnostic information in up to 20% of cases.

KW - Exome

KW - fetus

KW - genome

KW - sequencing

KW - structural abnormality

UR - https://authorea.com/doi/full/10.22541/au.158802269.98887041

U2 - 10.1111/1471-0528.16533

DO - 10.1111/1471-0528.16533

M3 - Article

C2 - 32975887

SN - 1470-0328

VL - 128

SP - 420

EP - 429

JO - BJOG: An International Journal of Obstetrics & Gynaecology

JF - BJOG: An International Journal of Obstetrics & Gynaecology

IS - 2

ER -

The role of next‐generation sequencing in the investigation of ultrasound‐identified fetal structural anomalies

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this